the present study was made to clarify the mechanisms of the antinephritic action of sa-446 , an angiotensin i converting enzyme inhibitor , on crescentic-type anti-gbm nephritis in rats as compared to the actions of spironolactone ( an antialdosterone agent ) , kallidinogenase ( a kallikrein agent ) and saralasin ( an angiotensin ii antagonist ) .
C0036193
saralasin
C0003009
angiotensin ii